Concepedia

Publication | Open Access

Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis

42

Citations

29

References

2017

Year

Abstract

NCT01721057; Results.

References

YearCitations

Page 1